Search research articles
Contact Us
Filters
Showing results (421-430 of 426) with videos related to
Page
of 43
Sort By:
You have reached the last page of results.
This site can display upto 426 results.
Journal of Medicinal Chemistry
|
June 1, 2007
Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion
Iain M McDonald, James W Black, Ildiko M Buck, et al.
British Journal of Cancer
|
February 20, 2008
Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
E Anderson, J Berg, R Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
S R Lakhani, B A Gusterson, J Jacquemier, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists
Ildiko M Buck, James W Black, Tracey Cooke, et al.
Journal of the National Cancer Institute
|
August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
S R Lakhani, J Jacquemier, J P Sloane, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2003
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS)
M O Leach, R A Eeles, L W Turnbull, et al.
Page
of 43
Search research articles
Search
Showing results (421-430 of 426) with videos related to
Sort By:
Page
of 43
You have reached the last page of results.
This site can display upto 426 results.
Journal of Medicinal Chemistry
|
June 1, 2007
Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion
Iain M McDonald, James W Black, Ildiko M Buck, et al.
British Journal of Cancer
|
February 20, 2008
Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold
E Anderson, J Berg, R Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
S R Lakhani, B A Gusterson, J Jacquemier, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists
Ildiko M Buck, James W Black, Tracey Cooke, et al.
Journal of the National Cancer Institute
|
August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
S R Lakhani, J Jacquemier, J P Sloane, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2003
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS)
M O Leach, R A Eeles, L W Turnbull, et al.
Page
of 43